Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies

BACKGROUND: Convalescent plasma is one of the treatment options for COVID-19 which is currently being investigated in many clinical trials. Understanding of donor and product characteristics is important for optimization of convalescent plasma. METHODS: Patients who had recovered from CO­VID-19 were...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transfus Med Hemother
Autori principali: Körper, Sixten, Jahrsdörfer, Bernd, Corman, Victor M., Pilch, Jan, Wuchter, Patrick, Blasczyk, Rainer, Müller, Rebecca, Tonn, Torsten, Bakchoul, Tamam, Schäfer, Richard, Juhl, David, Schwarz, Tatjana, Gödecke, Nina, Burkhardt, Thomas, Schmidt, Michael, Appl, Thomas, Eichler, Hermann, Klüter, Harald, Drosten, Christian, Seifried, Erhard, Schrezenmeier, Hubert
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger GmbH 2021
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8216018/
https://ncbi.nlm.nih.gov/pubmed/34177417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000515610
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi